GGrantIndex
Sort

51,593 grants matching hepatitis

Fully human recombinant therapeutic anti-vaccinia virus polyclonal antibody

$620,101
Johan Lantto · Symphogen A/S · U01 · FY2008 · AI

A novel vaccine to prevent HCV infection and hence liver cancer

$620,020
Ellen S Vitetta · Ut Southwestern Medical Center · RC2 · FY2010 · CA

CETP and HDL Function in Cardiovascular Diseases

$620,011
Yuqing E Chen · University Of Michigan At Ann Arbor · R01 · FY2016 · HL

In pursuit of a one-stop shop: a hybrid type 1 effectiveness-implementation trial of comprehensive tele-harm reduction for people who inject drugs

$619,921
Hansel Emory Tookes · University Of Miami School Of Medicine · R01 · FY2024 · DA

Obesity, chemotherapy dosing, and breast cancer outcomes

$619,893
Elizabeth David Kantor · Sloan-Kettering Inst Can Research · R37 · FY2019 · CA

Clinical Resources for Alcoholic Hepatitis Investigations

$619,879
Zhaoli Sun · Johns Hopkins University · R24 · FY2018 · AA

Coaching Performance Driven Practice Change in the Context of Value Based Purchasing Under New York Medicaid

$619,784
Charles J Neighbors · New York University School Of Medicine · R33 · FY2021 · DA

Lysosomal Regeneration (LysoGen) and Rescue as a Treatment for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

$619,776
Mark W Grinstaff · Boston University (Charles River Campus) · R01 · FY2025 · DK

Technology Development Project

$619,704
William Nicholas Haining · Massachusetts General Hospital · U19 · FY2009 · AI

CPCRA-PHILADELPHIA FIGHT

$619,696
Philadelphia Fight · U01 · FY2003 · AI

Ethnicity and fat deposition in obesity-related disease in youth

$619,583
Vicente Gilsanze · University Of Southern California · P60 · FY2009 · MD

Biochemistry of Protein Prenylation

$619,554
Michael H Gelb · University Of Washington · R01 · FY2010 · AI

Xanthine oxidase mediates the vascular dysfunction with direct and in-utero electronic cigarette exposure

$619,477
Paul D Chantler · West Virginia University · R56 · FY2024 · ES

Testing an mHealth System for Integrating Alcohol Use Treatment with Hepatology Care for Patients with Alcohol-associated Liver Disease

$619,476
Andrew Quanbeck · University Of Wisconsin-Madison · R01 · FY2025 · AA

Deep phenotyping of ANGPTL3, ANGPTL4 and ANGPTL8 human knockouts and population based studies

$619,439
Danish Saleheen · Columbia University Health Sciences · R01 · FY2022 · HL

On the regulation of hepatic glucose metabolism during insulin-induced hypoglycemia

$619,431
Jason Joseph Winnick · University Of Cincinnati · R01 · FY2025 · DK

Adenovirus hexon and its role in virus interaction with the host

$619,306
Dmitry Shayakhmetov · Emory University · R01 · FY2016 · AI

Molecular Regulation of LDL Receptor Expression

$619,239
Brian T Emmer · University Of Michigan At Ann Arbor · R01 · FY2025 · HL

Regulation of plasma LDL and HDL by microRNA-541-3p

$619,239
M Mahmood Hussain · New York University D/B/A Nyu Long Island School Of Medicine · R01 · FY2024 · HL

PCB-mediated dysbiosis of the gut microbiome: A missing link in PCB-mediated neurodevelopmental disorders?

$619,202
Hans-Joachim Lehmler · University Of Iowa · R01 · FY2024 · ES

PCB-mediated dysbiosis of the gut microbiome: A missing link in PCB-mediated neurodevelopmental disorders?

$619,202
Hans-Joachim Lehmler · University Of Iowa · R01 · FY2023 · ES

Analysis of immunity, viral adaptation and pathogenesis in a new mouse model of HCV-related rodent hepacivirus infection

$619,185
Charles M. Rice · Rockefeller University · R01 · FY2020 · AI

Quantitative studies of metabolic organ dynamics

$619,181
Richard N. Bergman · Cedars-Sinai Medical Center · R01 · FY2021 · DK

Gigapixel digital PCR in Giant Unilamellar Vesicles

$619,168
Adam R. Abate · University Of California, San Francisco · R01 · FY2022 · EB

Apolipoprotein M: a novel regulator of myocardial Autophagy

$619,115
Ali Javaheri · Washington University · R01 · FY2022 · HL